{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:23:32Z","timestamp":1792697012442,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P01HL028982"],"award-info":[{"award-number":["5P01HL028982"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL12082205"],"award-info":[{"award-number":["5T32HL12082205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.yjmcc.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T18:23:25Z","timestamp":1520360605000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction"],"prefix":"10.1016","volume":"118","author":[{"given":"Timothy D.","family":"Bryson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remonda M.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0005","doi-asserted-by":"crossref","first-page":"H1053","DOI":"10.1152\/ajpheart.00772.2010","article-title":"Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion","volume":"300","author":"Harding","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.03.005_bb0010","doi-asserted-by":"crossref","first-page":"H623","DOI":"10.1152\/ajpheart.00746.2009","article-title":"Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice","volume":"298","author":"Harding","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.03.005_bb0015","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/HYPERTENSIONAHA.107.102590","article-title":"Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction","volume":"51","author":"Qian","year":"2008","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.yjmcc.2018.03.005_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003291","article-title":"Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor","volume":"9","author":"Gu","year":"2016","journal-title":"Circ. Heart Fail"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.03.005_bb0025","doi-asserted-by":"crossref","first-page":"H1416","DOI":"10.1152\/ajpheart.00136.2003","article-title":"Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse","volume":"286","author":"LaPointe","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.yjmcc.2018.03.005_bb0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1113\/EP085104","article-title":"Fractalkine neutralization improves cardiac function after myocardial infarction","volume":"100","author":"Gu","year":"2015","journal-title":"Exp. Physiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.03.005_bb0035","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1152\/japplphysiol.00033.2007","article-title":"Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches","volume":"102","author":"Takagawa","year":"2007","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0040","doi-asserted-by":"crossref","first-page":"H1226","DOI":"10.1152\/ajpheart.00305.2007","article-title":"Novel anti-inflammatory mechanisms of N-acetyl-Ser-asp-Lys-pro in hypertension-induced target organ damage","volume":"294","author":"Sharma","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"14","key":"10.1016\/j.yjmcc.2018.03.005_bb0045","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.106.671198","article-title":"Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction","volume":"115","author":"Tsujita","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.03.005_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abio.1999.4085","article-title":"Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro","volume":"270","author":"Winer","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.yjmcc.2018.03.005_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hh1501.094396","article-title":"Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?","volume":"89","author":"Creemers","year":"2001","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0065","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1172\/JCI22304","article-title":"Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice","volume":"115","author":"Matsumura","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.03.005_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.RES.82.4.482","article-title":"Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function","volume":"82","author":"Spinale","year":"1998","journal-title":"Circ. Res."},{"issue":"20","key":"10.1016\/j.yjmcc.2018.03.005_bb0075","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.0000128046.54681.97","article-title":"Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4","volume":"109","author":"Xiao","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.03.005_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cvr\/cvn254","article-title":"Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia\/reperfusion injury","volume":"81","author":"Hishikari","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.104.508333","article-title":"Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury","volume":"112","author":"Martin","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/FJC.0b013e31820b7be1","article-title":"The anti-inflammatory mechanism of prostaglandin e2 receptor 4 activation in rat experimental autoimmune myocarditis","volume":"57","author":"Ngoc","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.03.005_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1536\/ihj.16-200","article-title":"An EP4 receptor agonist inhibits cardiac fibrosis through activation of PKA signaling in hypertrophied heart","volume":"58","author":"Wang","year":"2016","journal-title":"Int. Heart J."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.03.005_bb0100","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/01.CIR.93.6.1087","article-title":"Expression of inducible nitric oxide synthase in human heart failure","volume":"93","author":"Haywood","year":"1996","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.yjmcc.2018.03.005_bb0105","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.1074\/jbc.M110.187815","article-title":"Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of toll-like receptor signaling in alveolar macrophages","volume":"286","author":"Kim","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.yjmcc.2018.03.005_bb0110","doi-asserted-by":"crossref","first-page":"28902","DOI":"10.1074\/jbc.M111.235309","article-title":"Leukotrienes target F-actin\/cofilin-1 to enhance alveolar macrophage anti-fungal activity","volume":"286","author":"Morato-Marques","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.yjmcc.2018.03.005_bb0115","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.4049\/jimmunol.1203274","article-title":"Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant","volume":"190","author":"Domingo-Gonzalez","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0120","doi-asserted-by":"crossref","first-page":"H1229","DOI":"10.1152\/ajpheart.00207.2003","article-title":"Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction","volume":"285","author":"Hayashidani","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.yjmcc.2018.03.005_bb0125","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/13459","article-title":"Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure","volume":"5","author":"Heymans","year":"1999","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.03.005_bb0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/hc0602.103674","article-title":"Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction","volume":"105","author":"Lindsey","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.03.005_bb0135","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.CIR.0000046449.36178.00","article-title":"Myocardial infarct expansion and matrix metalloproteinase inhibition","volume":"107","author":"Mukherjee","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.03.005_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.20081244","article-title":"Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction","volume":"206","author":"Schellings","year":"2009","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.03.005_bb0145","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1006\/bbrc.2000.4137","article-title":"Construction of a human cardiovascular cDNA microarray: portrait of the failing heart","volume":"280","author":"Barrans","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0150","doi-asserted-by":"crossref","first-page":"H841","DOI":"10.1152\/ajpheart.01247.2010","article-title":"SPARC regulates collagen interaction with cardiac fibroblast cell surfaces","volume":"301","author":"Harris","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"46","key":"10.1016\/j.yjmcc.2018.03.005_bb0155","doi-asserted-by":"crossref","first-page":"44147","DOI":"10.1074\/jbc.M204810200","article-title":"Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor","volume":"277","author":"Takayama","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.03.005_bb0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0735-1097(99)00600-2","article-title":"The role of tumor necrosis factor in the pathophysiology of heart failure","volume":"35","author":"Feldman","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.03.005_bb0165","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/art.20164","article-title":"Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here?","volume":"50","author":"Khanna","year":"2004","journal-title":"Arthritis Rheum."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818300683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818300683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:53:31Z","timestamp":1778633611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818300683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":33,"alternative-id":["S0022282818300683"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.03.005","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}